Wolters Kluwer wins two A-Team Innovation Awards for excellence in integrated regulatory risk and data transformation
Recognition supports the OneSumX platform delivering high value for client banks
Wolters Kluwer Financial & Corporate Compliance has been recognized with two prestigious 2025 A-Team Innovation Awards for excellence in integrated regulatory risk, and financial data management. The awards celebrate innovative projects and teams across the vendor and practitioner communities that leverage new and emerging technologies to deliver high-value solutions for financial institutions.
"The A-team Innovation Awards underscore our commitment to delivering exceptional solutions and an unparalleled customer experience. Our solutions adeptly combine financial, risk, and regulatory metrics with modular and flexible configuration capabilities, ensuring responsiveness to an evolving landscape," said Jeroen Van Doorsselaere, Vice President, Global Product & Platform Management, Wolters Kluwer Finance, Risk & Regulatory Reporting. "Financial institutions recognize the immense value of our implementation approach and integrated solutions, along with our comprehensive understanding of industry nuances and proven track record of success."
The implementation of Wolters Kluwer's integrated regulatory and risk solutions at Indexo Bank was recognized by A-Team as the Most Innovative Project. Combining OneSumX for Regulatory Reporting and OneSumX for Risk in a fully integrated, SaaS-based setup, the implementation delivers end-to-end compliance with FINREP, COREP, Basel III, and IRRBB. Built for scalability, efficiency, and future growth, the solution supports Indexo Bank's goal to become a financial services group that empowers the people of Latvia to achieve prosperity, providing a solid regulatory and risk foundation to match its expanding business.
Wolters Kluwer was also recognized as the Most Innovative Data Transformation Project for the OneSumX for Finance implementation at a major European bank, which successfully transformed its fragmented finance and risk systems into a unified general ledger and centralized accounting and data hub. OneSumX for Finance established a single source of truth, by integrating financial, contract, counterparty, and reference data, ensuring consistency, and reducing the need for downstream reconciliation while simplifying reporting. It enabled real-time monitoring, daily reconciliation, and improved regulatory compliance while streamlining the system landscape to lower costs and operational complexity.
Finance, Risk, and Regulatory Reporting (FRR) is part of Wolters Kluwer’s Financial & Corporate Compliance (FCC) division, which provides a wide range of technology-enabled lending, regulatory and investment compliance solutions, corporate services, and legal entity compliance solutions. FRR’s award-winning OneSumX suite of solutions supports financial institutions through innovative technology that enables and empowers clients to stay compliant with everchanging regulatory requirements, manage uncertainty through finance and risk management offerings, and drive efficiency.
For more information, please visit: OneSumX Finance, Risk, and Regulatory Reporting.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250501488185/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MAG Signs Strategic Partnership with MultiBank Group to Tokenize $3 Billion Real Estate Assets1.5.2025 16:30:00 CEST | Press release
MAG, the leading real estate developer in the UAE has signed a historic $3 billion tokenization agreement with MultiBank Group, the world’s largest financial derivatives institution based in Dubai, and Mavryk, a leading blockchain innovator — marking the largest real-world asset (RWA) tokenization initiative globally to date. The initiative highlights the imminent launch of $MBG, the utility token at the core of MultiBank’s next-generation digital finance ecosystem. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501021414/en/ The Ritz-Carlton Residences, Dubai, Creekside at the Keturah Resort (Photo: AETOSWire) The partnership will bring MAG’s high-value real estate developments — The Ritz-Carlton Residences, Dubai, Creekside, part of the Keturah Resort, and Keturah Reserve — onto the blockchain, making them available to global investors via MultiBank.io’s fully regulated RWA marketplace. Once launched, holders of the RWA
Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges1.5.2025 16:00:00 CEST | Press release
Along with PCI’s own robust infrastructure expansions, acquisition furthers CDMO’s recent growth in sterile fill-finish, advanced drug delivery systems like prefilled syringes and cartridges, and biologics – including high potent assets for antibody-drug conjugates. PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – has completed its acquisition of Ajinomoto Althea, Inc. (“Althea”), a US-based sterile fill-finish CDMO and subsidiary of Japan-based Ajinomoto Co., Inc. For PCI, the acquisition is a cornerstone of a multi-year investment strategy spanning facilities in the United States and Europe. In the United States, Althea’s assets combine with PCI’s existing sterile fill-finish and advanced drug delivery operations to form a world-class, large-scale manufacturing hub in San Diego, complete with state-of-the-art large-scale aseptic facilities for prefilled syringes and cartridges. Among
Boomi Launches DataHub Command Center, Powered by ServiceNow, Enabling Organizations to Unlock the Full Potential of Their Data1.5.2025 15:00:00 CEST | Press release
Boomi™, the intelligent integration and automation leader, today announced the general availability of Boomi DataHub Command Center, a new module within Boomi DataHub that unifies data from disparate sources, simplifies governance, and promotes actionable insights. Powered by the enterprise-grade workflows on the ServiceNow® Platform and managed entirely by Boomi, Boomi DataHub Command Center empowers organizations to unlock the full potential of their data through interactive visualization, robust traceability, and historical analysis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501619915/en/ Boomi Launches DataHub Command Center, Powered by ServiceNow, Enabling Organizations to Unlock the Full Potential of Their Data Modern businesses are increasingly challenged by disconnected data systems, unclear data lineage, and insufficient oversight—barriers that stifle growth and innovation. According to Forrester, global dat
Harini Gopalakrishnan Joins Vespa.ai as General Manager of Health & Life Sciences1.5.2025 15:00:00 CEST | Press release
Former Global CTO for Life Sciences at Snowflake to Lead Vespa’s Expansion into the Sector Vespa.ai, the platform for large-scale, real-time AI applications powered by big data, today announced the appointment of Harini Gopalakrishnan as General Manager of Health & Life Sciences. Gopalakrishnan, formerly Global CTO for Life Sciences at Snowflake, will spearhead Vespa’s strategic initiatives in the sector. Vespa.ai provides the infrastructure to build and deploy AI-driven applications for search and retrieval-augmented generation (RAG), offering precise, real-time access to large language models (LLMs). In Health and Life Sciences, this capability enables teams to search, connect, and extract insight from complex multimodal data, accelerating research, clinical decision-making, and commercial innovation. Harini Gopalakrishnan, GM Health & Life Sciences, Vespa.ai: “AI’s success in life sciences depends on unlocking insights across vast data, where one navigates a complex ecosystem of mul
Crown Bioscience and NEXT Oncology Cement Partnership Extension1.5.2025 14:30:00 CEST | Press release
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, is pleased to announce the extension of its partnership with NEXT Oncology, one of the world’s largest Phase I Oncology Clinical Trial networks. This strategic partnership will continue to leverage Crown Bioscience's extensive experience in developing clinically relevant cancer organoid and patient-derived xenograft (PDX) models, together with NEXT Oncology's global clinical network and Phase I clinical trials expertise. Through this extended agreement, Crown Bioscience reaffirms its exclusive rights to provide services based on patient samples sourced from NEXT Oncology’s industry-leading global clinical trial network. This collaboration underscores Crown Bioscience's commitment to providing the most clinically relevant PDX and organoid models and solutions for translational oncology research. "We are thrilled to continue our
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom